Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
126,337,406
Share change
+4,914,095
Total reported value
$3,169,441,114
Put/Call ratio
26%
Price per share
$25.12
Number of holders
275
Value change
+$136,709,726
Number of buys
139
Number of sells
147

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q4 2025

As of 31 Dec 2025, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 275 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 126,337,406 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, MORGAN STANLEY, Deep Track Capital, LP, RTW INVESTMENTS, LP, BlackRock, Inc., STATE STREET CORP, UBS Group AG, and SUVRETTA CAPITAL MANAGEMENT, LLC. This page lists 275 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.